How is cross‑matching performed for packed red blood cell transfusion?

Cross-Matching for Packed RBC Transfusion

Cross-matching for packed RBC transfusion requires obtaining a properly labeled blood sample from the patient, performing ABO/RhD typing at minimum (with extended antigen profiling preferred), conducting antibody screening, and then performing serological compatibility testing between recipient serum and donor red cells using either tube method or column agglutination technology. 1

Pre-Transfusion Sample Collection and Patient Identification

The foundation of safe cross-matching begins with proper sample collection and patient identification:

• Collect blood samples with four core identifiers: first name, last name, date of birth, and patient identification number 2
• Ensure the patient wears an identification wristband with these same four identifiers
• Critical pitfall: Misidentification is the most common transfusion risk and the most serious outcome of blood transfusion 1
• For unidentified patients in emergencies, assign a unique identification number with "unknown male/female" designation; if identity becomes known later, collect a new sample with correct details 2

Blood Typing Strategy

The extent of typing depends on clinical context and patient history:

Standard Approach:

• Minimum requirement: ABO and RhD typing 1
• Preferred approach: Extended red cell antigen phenotype including Rh (C/c, E/e) and K antigens 3
• Most comprehensive: Extended profile including Jka/Jkb, Fya/Fyb, M/N, and S/s antigens to expedite antibody identification if incompatibility develops 3

Special Populations:

For patients with sickle cell disease or those with previous transfusions, extended antigen profiling is particularly important as it reduces alloimmunization risk and expedites compatible unit selection when antibodies develop 3.

Cross-Matching Methods

Two primary techniques are used, with comparable efficacy:

1. Conventional Tube Method:

• Mix recipient serum with donor red cells
• Perform immediate spin phase
• Include anti-human globulin (AHG) phase unless patient has no significant unexpected antibodies 4
• Limitation: Using only immediate spin crossmatch carries a risk of 1 acute hemolytic reaction per 250,000 crossmatches when clinically significant antibodies are missed 4

2. Column Agglutination Technology (CAT):

• Uses polyspecific (IgG + C3d) gel media 5
• Advantages over tube method: No wash phase required, no controls needed, rapid results, comparable sensitivity and specificity 6
• Preferred modern approach in many centers

Antibody Screening and Identification

Perform antibody screening on all patients before crossmatching 1:

• If antibody screen is negative and no history of antibodies, immediate spin crossmatch may be acceptable
• If antibody screen is positive (occurs in 0.69% of samples), proceed with:
  • Direct antiglobulin test (DAT)
  • Auto control
  • Antibody identification using panel cells 5

Common antibodies causing incompatibility: Anti-E is most frequent, followed by other Rh system antibodies, anti-K, anti-Jka, and anti-Fya 5

Emergency Transfusion Protocols

When cross-matching time is not available 1:

1. Extreme emergency (life-threatening hemorrhage):

   • Issue O Rh-negative packed RBCs (maximum 2 units)
   • O Rh-positive acceptable for males or postmenopausal females

2. Urgent situation (blood group known):

   • Issue ABO group-specific uncrossmatched blood
   • Laboratory completes crossmatch after issue

3. Standard situation:

   • Issue fully crossmatched blood
   • After replacement of 1 blood volume (8-10 units), further crossmatching not required for additional units from same donors 1

Managing Incompatible Crossmatches

When crossmatch is incompatible 5:

• Recheck in duplicate with two additional group-specific donor units
• If persistent incompatibility, perform full antibody workup
• If panagglutination occurs (17% of incompatible cases), provide Rh and Kell phenotype-matched or best-matched units
• Note: 38% of incompatible crossmatches may be positive only on indirect antiglobulin test, not on immediate spin 5

Final Bedside Verification

Before transfusion, perform bedside check 2:

• Verify four core identifiers on compatibility label match patient wristband exactly
• Confirm blood group and 14-digit donation number on compatibility label matches unit label
• Visually inspect unit for leakage, discoloration, clots, or clumps
• Check expiry date and time
• Complete transfusion within 4 hours of removal from blood fridge 2

Documentation Requirements

• All transfusions must be documented in patient record 2
• 100% traceability is a legal requirement 2
• Record all crossmatch procedures and any incompatibilities in laboratory records

This systematic approach prioritizes patient safety through proper identification, appropriate typing based on clinical context, validated serological testing, and meticulous verification at every step.